![](https://endpts.com/wp-content/uploads/2023/09/Amy-Emerson-MAPS-Public-Benefit-Corporation-CEO.jpg)
Amy Emerson, MAPS Public Benefit Corporation CEO
MAPS plans to seek approval of MDMA-assisted therapy this year after second positive PhIII trial
MAPS Public Benefit Corporation is touting another set of promising Phase III results investigating its MDMA-assisted therapy for post-traumatic stress disorder (PTSD), with the trial …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.